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Abstract
Background
Long-term acute care hospitals (LTACs) provide specialized treatment for patients with
chronic critical illness. Increasingly LTACs are co-located within traditional short-stay hospi-
tals rather than operated as free-standing facilities, which may affect LTAC utilization pat-
terns and outcomes.
Methods
We compared free-standing and co-located LTACs using 2005 data from the United States
Centers for Medicare & Medicaid Services. We used bivariate analyses to examine patient
characteristics and timing of LTAC transfer, and used propensity matching and multivari-
able regression to examine mortality, readmissions, and costs after transfer.
Results
Of 379 LTACs in our sample, 192 (50.7%) were free-standing and 187 (49.3%) were co-
located in a short-stay hospital. Co-located LTACs were smaller (median bed size: 34 vs.
66, p <0.001) and more likely to be for-profit (72.2% v. 68.8%, p = 0.001) than freestanding
LTACs. Co-located LTACs admitted patients later in their hospital course (average time
prior to transfer: 15.5 days vs. 14.0 days) and were more likely to admit patients for ventila-
tor weaning (15.9% vs. 12.4%). In the multivariate propensity-matched analysis, patients in
co-located LTACs experienced higher 180-day mortality (adjusted relative risk: 1.05, 95%
CI: 1.00–1.11, p = 0.04) but lower readmission rates (adjusted relative risk: 0.86, 95% CI:
0.75–0.98, p = 0.02). Costs were similar between the two hospital types (mean difference in
costs within 180 days of transfer: -$3,580, 95% CI: -$8,720 –$1,550, p = 0.17).
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Conclusions
Compared to patients in free-standing LTACs, patients in co-located LTACs experience
slightly higher mortality but lower readmission rates, with no change in overall resource use
as measured by 180 day costs.
Background
Long-term acute care hospitals (LTACs) are a unique type of inpatient health care facility in
the United States (US), providing specialized care to acutely ill patients requiring extended hos-
pitalizations [1]. Defined by the US Centers for Medicare and Medicaid Services (CMS) as
acute care hospitals with an average length of stay greater or equal to 25 days, LTACs were
formally established in the early 1980’s during the shift towards prospective payment for US
hospitals, under which hospitals are paid a set amount for each payment rather than have pay-
ments determined by costs [2]. At the time, the creators of the prospective payment system
realized that a small subset of hospitals, typically respiratory hospitals with a focus on inpatient
rehabilitation of patients with chronic respiratory needs, were systematically different than
other acute care hospitals and might not be financially viable were they to be paid under the
same prospective payment system. CMS therefore exempted hospitals with long geometric
mean lengths of stay from prospective payment, codifying into payment policy the class of hos-
pitals known as LTACs.
Over time, LTACs have evolved from purely respiratory-focused hospitals to hospitals that
provide care for patients with all types of chronic critical illness [3]. Generally, this means that
patients are transferred from short stay hospitals to LTACs when they have recovered from
their acute illness (and therefore don’t require all the resources of an acute care hospital) but
still have substantial inpatient needs (and therefore can’t be transferred to other types of post-
acute care such as skilled nursing facilities or inpatient rehabilitation hospitals) [4]. Most com-
monly, patients are transferred for prolonged mechanical ventilation necessitating intensive
ventilator weaning, severe wounds, the need for ongoing hemodialysis and other low-intensity
organ support, and other types of chronic critical illness, directly from traditional short stay
hospitals [5]. Although LTACs are unique to the United States, many industrial nations have
similar types of hospitals that focus on the care of the long-term ventilator patients [6,7].
LTACs are among the fastest growing segments of the health care system [8]. The number
of LTACs increased from 277 in 2003 to 412 in 2010, with Medicare spending on LTACs dur-
ing this period increasing from $2.7 billion to $5.2 billion [9]. The reasons for this increase are
complex but may be attributable to several primary factors. First, the prevalence of prolonged
mechanical ventilation is increasing due to the aging of the population and advances in the
care of critically ill patients that leads to greater survivorship but also greater short-term dis-
ability [10]. Second, the US prospective payment system creates financial incentives for LTAC
transfer, since hospitals can increase revenue by discharging patients “sicker and quicker” but
still receiving the same payment [11]. As a consequence of this growth, LTACs are an impor-
tant policy problem in the United States.
Historically most LTACs operated as free-standing health care facilities. However, most of
the recent growth in LTACs has occurred in the form of co-located hospitals, also known as
“hospitals within a hospital” [9]. Co-located LTACs differ from free-standing LTACs in that
they are physically located within traditional short stay hospitals even though they are organi-
zationally, managerially and financially independent from their host hospital. This arrange-
ment may increase efficiency by allowing them to share some resources with their host hospital
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such as radiological and procedural services. However, co-location also reduces the barriers to
LTAC transfer, potentially leading to unnecessary transfers and overutilization.[12] Concerned
about potential overutilization, Medicare has advanced plans to limit transfers to co-located
LTACs, reducing payments if more than 25% of co-located LTACs patients come from a single
hospital [9].
This policy, known as the “25% rule” has not yet been fully implemented due to repeated
Congressional delays—current regulations reduce payments if transfer thresholds exceed 50%
for co-located LTACs. Moreover current proposals for the 25% rule include all LTACs, not just
free-standing LTACs. Yet if fully implemented, this policy will ultimately discourage the use of
co-located LTACs. Yet it is not clear whether the co-located LTAC model should be encour-
aged or discouraged, since the actual differences between co-located and free-standing LTACs
are not well described. Co-location, a form of vertical integration, could improve outcomes and
lower costs by allowing LTACs to afford themselves of the specialized services of short stay
hospitals [13]. Co-location could also worsen outcomes and increase costs since co-located
LTACs are typically smaller than free-standing LTACs and thus have less clinical experience in
the care of critically ill patients [14]. To better understand these issues, we used data on fee-for-
service Medicare beneficiaries to compare patient characteristics and outcomes between free-
standing and co-located LTACs.
Methods
Study design and data
We performed a retrospective cohort study of Medicare beneficiaries transferred from United
States short stay hospitals to LTACs in calendar year 2005. We obtained patient-level data
from the Medicare Provider Analysis and Review (MedPAR) file, which contains the final
action hospitalization claims for all fee-for-service Medicare beneficiaries in the United States,
including both short stay hospitals, skilled nursing facility (SNF) admissions, and LTACs.
Medicare is the payer for over two-thirds of all LTAC hospitalizations and is the only national
source of data for LTAC admissions [1]. We obtained hospital-level data from the CMS
Healthcare Cost Report Information System (HCRIS). Short stay hospitals and LTACs were
identified in HCRIS, as previously described [15].
Patients
All patients admitted to a short stay hospital during 2005 were initially eligible. To create a
homogenous cohort we limited the analysis to patients aged 66 and over and patients who were
community dwelling prior to their short stay hospital admission. We defined community
dwelling as not being admitted to a short-stay hospital, SNF or LTAC immediately prior to
their index short stay hospital admission, i.e. nursing home residents and patients at home
were considered community dwelling. To avoid interdependence of observations we analyzed
only the first short-stay hospital admission for each patient.
Variables
The primary exposure variable was the type of LTAC to which the patient was transferred:
either free-standing or co-located. We identified LTAC transfers by directly observing them in
the claims rather than using the “discharge location” field in MedPAR which is known to be
inaccurate [15]. We identified co-located LTACs in two ways. First, we used a preliminary list-
ing of co-located LTACs provided by the Centers for Medicare & Medicaid Services. Second,
we geocoded all US short stay hospitals and LTACs using ArcGIS software (ESRI, Redlands,
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California) based on their street address listed in HCRIS. We then calculated the linear arc dis-
tance between each LTAC and the nearest short-stay hospital. For LTACs located less than one
mile to the nearest short-stay hospital we performed internet searches to determine the LTAC
type. We reconciled differences between these two lists by making direct phone calls to the
hospitals.
The primary outcome variables were mortality (30, 90 and 180 days, measured from the
date of transfer to the LTAC); all-cause hospital readmissions (which we defined in two ways:
within 30-days of LTAC transfer whether or not the patient remained at the LTAC; and during
the LTAC stay regardless of timing); LTAC length of stay in days; LTAC costs, and 180-day
hospitalization-related costs from the date of LTAC transfer, including LTAC costs and addi-
tional short stay hospital or skilled nursing costs. These variables were chosen because of their
importance to patients, in the case of mortality; and society, in the case of readmissions, length
of stay and costs. Mortality was calculated from observed death dates in the Medicare Benefi-
ciary Summary Files. Readmissions and LTAC length of stay were determined directly from
the claims. Costs were determined from total charges reported in the claims multiplied by hos-
pital-specific cost-to-charge ratios from HCRIS [16]. Because we were interested in readmis-
sions and length of stay due to their relation to resource use, we did not specifically address the
potential for informative censoring due to mortality. Instead, these outcomes are meant to be
considered separately.
Analysis
We designed the analysis to answer three questions: (1) do LTAC types differ in organizational
characteristics? (2) do LTAC types differ in the types of patients admitted and the timing of
transfer for admitted patients? and (3) do patient outcomes differ between LTAC types? To
answer the first question we compared LTAC characteristics between free-standing and co-
located LTACs using two-sample t-tests, chi-square tests and Wilcoxon rank-sum tests, as
appropriate. To answer the second question we compared patient characteristics by transfer
destination, either free-standing or co-located LTAC. For this analysis we did not perform sta-
tistical hypothesis testing, since due to the large number of patients any differences would be
statistically significant even if not clinically significant.
To answer the third question, we compared patient outcomes between free-standing and
co-located LTACs. To minimize confounding, for this analysis we limited the cohort to
patients with the 10 most common diagnoses resulting in an LTAC transfer, using diagnosis
related group (DRG) from the short stay hospital. These 10 diagnoses accounted for 42.5% of
all LTAC transfers during this year. We further limited the analysis to Dartmouth Atlas Hospi-
tal Referral Regions with both types of LTACs; short stay hospitals that transferred patients to
both types of LTACs; and short stay hospitals with at least 25 eligible patients.
Patients admitted to a short-stay hospital containing a co-located LTAC are both more
likely to be transferred to an LTAC in general and more likely to be transferred to a co-located
LTAC in particular [12], and both of these decisions may be associated with patient outcomes.
We used a propensity score to account for the bias inherent in this comparison [17,18]. First,
we created a propensity score for transfer to a co-located LTAC using a multivariable regres-
sion model that included all patient and hospital factors potentially related to LTAC transfer.
We derived the score based on all eligible patients, including those not-transferred to an
LTAC, so that the propensity score would best estimate the probability of admission to an
LTAC type; fitting a multinomial regression model in which the outcome was the entire range
of potential outcomes: dead or hospice, home, skilled nursing facility, another short-stay hospi-
tal, a co-located LTAC, or a free standing LTAC. Thus, the propensity score accounted for not
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only the propensity to be admitted to a co-located LTAC but also the propensity to be trans-
ferred to an LTAC in general, instead of being transferred to a post-acute care facility or dying
in the hospital.
After creating the propensity score we excluded patients who were not transferred to an
LTAC. We then matched the remaining patients based on their propensity to be transferred to
a co-located LTAC, using a combined nearest-neighbor and Mahalanobis matching procedure
[19]. As a result, the analytic cohort in this step contained only patients who were transferred
to an LTAC and were of equal likelihood to be transferred to a co-located LTAC. In this cohort
we then performed multivariable regression examining the relationship between LTAC type
and outcomes, controlling for patient and short-stay hospital characteristics. We used general-
ized linear models to account for the different distributional forms of the outcome variables.
Additional details regarding the propensity matching and regression analysis, including an
expanded rationale for this approach, are available in the S1 File.
Analyses were performed with SAS 9.3 (SAS Institute, Cary, NC). All statistical tests were
two-tailed, and a p-value of0.05 was considered significant. This work used existing de-iden-
tified data and was considered exempt from the requirement for informed consent by the Uni-
versity of Pittsburgh Institutional Review Board. All data related to this manuscript are
publically available from the United States Centers for Medicare and Medicaid Services, subject
to an application and data use agreement (www.resdac.org).
Results
The study included 379 LTACs of which (49.3%) were co-located in a short stay hospital. Com-
pared to free-standing LTACs, co-located LTACs were smaller; were more likely to be for-
profit; and, on average, admitted patients from fewer short-stay hospitals (Table 1).
The analysis of patient differences between hospital types included 77,170 patients in these
379 LTACs. Compared to patients admitted to free-standing LTACs, patients admitted to co-
located LTACs were more likely to have been in an ICU in the short stay hospital, were more
likely to be transferred for ventilator weaning, and had longer hospital stays (Table 2).
The analysis of outcome differences between LTAC types included 289 LTACs that admit-
ted 391,292 patients from 771 acute care hospitals (Fig 1). Of the 391,292 eligible patients,
Table 1. Long-term acute care hospital characteristics by type.
Characteristic Free-standing (n = 192) Co-located (n = 187) P-value
Bed size 66 [40–109] 34 [30–44] <0.0001
Ownership 0.001
For-proﬁt 132 (68.8) 135 (72.2)
Non-proﬁt 40 (20.8) 49 (26.2)
Government 20 (10.4) 3 (1.6)
Region 0.0002
Northeast 32 (16.7) 18 (9.4)
South 95 (49.5) 114 (59.4)
Midwest 35 (18.2) 47 (24.5)
West 30 (15.6) 8 (4.2)
Number of different short stay hospitals from which patients were admitted 18.4 ± 8.7 12.8 ± 6.6 <0.001
Total admissions in MedPAR* 228 [95–361] 182 [114–251] 0.008
Values are median [interquartile range], frequency (percent) or mean ± standard deviation.
MedPAR = Medicare Provider Analysis and Review File.
*The total number of 2005 admissions in MedPAR independent of eligibility for this study.
doi:10.1371/journal.pone.0139742.t001
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322,692 (82.5%) were admitted to short stay hospitals without a co-located LTAC and 68,330
(17.5%) were admitted to short stay hospitals with a co-located LTAC. As in previous studies
[12], patients in hospitals with a co-located LTAC were more likely to be transferred to an
LTAC than patients in hospitals without a co-located LTAC (4.8% versus 2.5%, p<0.001), and
were also more likely be transferred to a co-located LTAC (81.7% versus 33.6% of all LTAC
transfers, p<0.001) (Fig 2). Overall, 48.8% of patients admitted to a co-located LTAC were
admitted from the host hospital as opposed to a different hospital. An examination of the char-
acteristics and outcomes of all patients with these DRGs, not just those transferred to LTACs,
is shown in the S1 File.
Of the 11,084 patients transferred to an LTAC, we excluded 216 patients with the rare trans-
fer pattern of having originated in a hospital containing a co-located LTAC and transferred to
a co-located LTAC hosted by a different hospital (i.e. not the LTAC co-located within their
hospital). These patients represented 2.0% of all LTAC transfers and 8.2% of all LTAC transfers
from hospitals containing a co-located LTAC. This left 10,868 LTAC patients for the propen-
sity matched analysis.
Table 2. Patient characteristics for all patients transferred to long-term acute care hospitals.
Free-standing (n = 44,973) Co-located (n = 32,197)
Age 78.5 ± 7.4 77.8 ± 7.2
Female (%) 25554 (56.8) 17798 (55.3)
Race
White 34376 (76.4) 25272 (78.5)
Black 7246 (16.1) 5464 (17.0)
Other 3351 (7.5) 1461 (4.5)
Admitted to ICU at short stay hospital 19001 (42.2) 16257 (50.5)
MV status
Short stay only 4446 (9.9) 3778 (11.7)
Short stay and LTAC 5557 (12.4) 5106 (15.9)
LTAC only 847 (1.9) 595 (1.8)
Neither 34123 (75.9) 22718 (70.6)
Length of Stay
ICU 7.6 ± 11.7 8.9 ± 12.0
Hospital 14.0 ± 12.6 15.5 ± 12.4
Diagnosis related group
Tracheostomy with MV 96 (541/542) 5931 (13.2) 5396 (16.8)
Septicemia (416) 2357 (5.2) 1640 (5.1)
Intracranial hemorrhage (14) 2016 (4.5) 910 (2.8)
Pneumonia with CC (89) 1894 (4.2) 981 (3.0)
Respiratory diagnosis with MV (475) 1554 (3.5) 1237 (3.8)
Heart failure and shock (127) 1736 (3.9) 1048 (3.3)
COPD (88) 1472 (3.3) 642 (2.0)
Major bowel procedure with CC (148) 993 (2.2) 1098 (3.4)
Respiratory infection/inﬂammation w/ CC (79) 1218 (2.7) 840 (2.6)
OR procedure for infection (415) 972 (2.2) 1000 (3.1)
All others 24830 (55.1) 17405 (54.1)
ICU = intensive care unit; LTAC = long-term acute care hospital; MV = mechanical ventilation; CC = comorbidity or complication; COPD = chronic
obstructive lung disease
doi:10.1371/journal.pone.0139742.t002
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Patient characteristics for the final propensity-matched cohort are shown in Table 3. In the
matched sample, patients in co-located LTACs were less likely to be mechanically ventilated or
have been admitted to an ICU, but overall the cohorts were more similar, compared to patients
in free-standing LTACs. Unadjusted and adjusted outcomes in the propensity-matched cohort
are shown in Table 4 and Table 5, respectively. Adjusted mortality was higher among patients
transferred to co-located LTACs, both at 30, 90 and 180 days. This mortality difference per-
sisted even after controlling for total annual admission volume. Conversely, the risk for read-
mission was slightly lower, both in 30-days and during the entire LTAC stay. Costs were
generally similar between the two groups.
Discussion
In a national cohort of Medicare beneficiaries we found that admission to a co-located LTAC is
associated with increased mortality but decreased hospital readmission rates, even after
Fig 1. Flow diagram of hospitals and patients. The LTAC-level analysis (Table 1) contains the 379 LTACs in the continental United States with at least 1
Medicare admission. The patient level analyses examining patient characteristics between LTAC types (Table 2) also contains patients in these 379 LTACs.
The outcomes analysis (Tables 3 and 4) contains the 289 LTACs in the final analysis and 10,118 patients in the matched sample. LTAC = long-term acute
care hospital; DRG = diagnosis related group; HCRIS = Healthcare Cost Reporting Information System.
doi:10.1371/journal.pone.0139742.g001
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controlling for patient characteristics and patient selection. We also found that, when consider-
ing similar patient types, co-located LTACs tend to admit patients later in their hospital course,
and are more likely to admit patients for ventilator weaning, compared to free-standing
LTACs.
The higher mortality in co-located LTACs may be due to several factors. Co-located LTACs
are smaller than free-standing LTACs, and may not have the economies of scale to avail them-
selves of intensivist physician staffing [20] or multidisciplinary care teams [21] which are
known to save lives in the ICU setting. Additionally, the mortality difference may be due to dif-
ferences in application of protocols for sedation and weaning from mechanical ventilation
[22]. Since co-located LTACs are organizationally distinct from their host hospitals (sharing
space and some services but nothing else), they would not be expected to directly obtain this
expertise from their host hospitals.
Another possible cause could be the influence of the host hospital itself. If the LTAC clini-
cians are reassured by the availability of the host hospital’s services and clinicians they may be
more reluctant to transfer unstable patients back to the short stay hospital. We also cannot rule
out unmeasured differences in severity of illness or other selection–based factors, since our
Fig 2. Discharge destination of eligible patients, limited to patients transferred to a long-term acute hospital, by originating hospital type
(n = 11,084). LTAC = long-term acute care hospital.
doi:10.1371/journal.pone.0139742.g002
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study did not use clinical risk adjustment and the absolute mortality differences were small.
We did address whether the observed differences may be due to the difference in volume itself,
since volume-outcome relationships are well described in patients with critical illness [14]. Our
mortality estimates persisted after adjusting for annual volume, making this explanation
unlikely.
The lower readmission rate we observed is potentially due to the fact that co-located LTACs
can avail themselves of the services of short stay hospitals in the care of their patients, including
Table 3. Patient characteristics for propensity-matched cohort of patients transferred to long-term
acute care hospitals. This represents a restricted sample of all patients transferred to LTACs. A table show-
ing all patients eligible for the match, including those not successfully matched, are described in the S1 File.
Matched Sample
Free-standing (n = 5,059) Co-located (n = 5,059)
Age 78.1 ± 7.4 78.5 ± 7.5
Female (%) 2692 (53.2) 2,829 (55.9)
Race
White 3,924 (77.6) 3,818 (75.5)
Black 931 (18.4) 969 (19.2)
Other 204 (4.0) 272 (5.3)
Admitted to ICU at short stay hospital 3,455 (68.3) 3,262 (64.5)
Mechanical ventilation status
Short stay only 994 (19.6) 966 (19.1)
Short stay and LTAC 1,612 (31.9) 1,874 (37.0)
Neither 2,388 (47.2) 2,170 (42.9)
Length of stay in short stay hospital
ICU 15.2 ± 15.4 14.1 ± 14.9
Hospital 20.3 ± 15.4 18.9 ± 15.0
ICU = intensive care unit; LTAC = long-term acute care hospital
doi:10.1371/journal.pone.0139742.t003
Table 4. Unadjusted outcomes for the propensity-matched cohort of patients transferred to long-term
acute care hospitals.
Free-standing (n = 5,059) Co-located (n = 5,059)
Mortality
90 days 2,298 (45.2) 2,147 (42.4)
180 days 2,665 (52.7) 2,504 (49.5)
365 days 3,024 (59.8) 2,907 (57.5)
Readmissions, all patients
30-day 1,643 (32.5%) 1,556 (30.8%)
During LTAC stay 827 (16.4%) 778 (15.4%)
Readmissions, survivors (n = 8,044)
30-day 1,615 (39.4%) 1,535 (38.9%)
During LTAC stay 766 (18.7%) 724 (18.3%)
Costs
LTAC stay $42,959 ± $50,550 $43,613 ± $57,573
180 day $45,731 ± $64,140 $49,331 ± $66,711
ICU = intensive care unit; LTAC = long-term acute care hospital
doi:10.1371/journal.pone.0139742.t004
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subspecialty consults and radiological evaluation. Patients in co-located LTACs requiring these
services need not be transferred back to short stay hospitals to receive them, reducing the need
for readmission. Under a prospective-payment model, this benefit might reduce LTAC costs to
payers, who then do not have to pay for additional hospital admissions. Nonetheless, it does
not appear to reduce overall costs, which were not significantly different between the two study
types. Alternatively, this finding could be due to competing risks, since we observed increased
mortality in co-located hospitals and decedents are no-longer at risk for readmissions.
Co-located LTACs tended to admit more sick patients overall (in that they were more likely
to have been in in ICU and more likely to have been mechanically ventilated), and admit
patients later in their hospital course, even after minimizing differences between the two
groups through propensity matching. This finding highlights the fact that there is little stan-
dardization about when patients should be transferred to LTACs, leading to variation in trans-
fer timing by LTAC type. Currently there are no universally accepted criteria to define
eligibility for LTAC transfer [3]. This opens the possibility that LTACs are selecting patients
based on factors other than clinical appropriateness. Our study suggests that co-located LTACs
are indeed selecting different types of patients for admission. This finding also shows that acute
care hospitals with greater access to LTACs may be more profitable under prospective pay-
ment, since they are able to discharge patients earlier, spending less money but receiving the
same fixed payments. Prior studies show that hospitals that host co-located LTACs tend to
experience shorter lengths of stay and lower costs for ICU patients [23], supporting the notion
Table 5. Adjusted outcomes among patients transferred to a co-located LTAC compared to a free-
standing LTAC (n = 10,118).*
Outcome measure Estimate 95% CI P value
Mortality (RR)
30 days 1.07 (1.00, 1.15) 0.06
90 days 1.06 (1.00, 1.13) 0.04
180 days 1.05 (1.00, 1.11) 0.04
30-day readmissions (RR)
All patients 0.91 (0.84, 0.98) 0.02
Survivors only (n = 8,044) 0.94 (0.88, 1.01) 0.09
Readmissions during LTAC stay (RR)
All patients 0.86 (0.75, 0.98) 0.02
Survivors only (n = 8,044) 0.89 (0.79, 1.01) 0.08
LTAC length of stay, days (mean difference)
All patients -1.11 (-2.47, 0.26) 0.11
Survivors only (n = 8,044) -0.41 (-1.76, 0.94) 0.55
LTAC costs, thousands (mean difference)
All patients 2.19 (-4.41, 8.79) 0.51
Survivors only (n = 8,044) 3.75 (-2.57, 10.08) 0.24
180 day costs, thousands (mean difference) -3.58 (-8.72, 1.55) 0.17
*Patients were matched based on their propensity for transfer to a co-located LTAC as well their ventilation
status, ICU admission status and the presence of a co-located LTAC in their admission short stay hospital.
All models adjust for age, gender, short stay hospitalization length of stay, short stay hospital admission
source ventilation status, ICU admission status, patient comorbidities deﬁned in the manner of Elixhauser
and annual hospital volume. Models also account for clustering by LTAC using generalized estimating
equations.
LTAC = long-term acute care hospital; CI = conﬁdence interval; RR = relative risk
doi:10.1371/journal.pone.0139742.t005
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that co-located LTACs approach patients differently at their host hospitals compared to other
hospitals. Together, these results highlight the need to better standardize LTAC admission cri-
teria, a process that is currently underway. Unfortunately, our data are not granular enough to
determine the clinical appropriateness of transfer in this study.
Overall, our study implies a tradeoff between these two types of post-acute care facilities,
with a small increased risk of mortality exchanged for a lower readmission rate. This tradeoff
potentially suggests that the best LTAC model may be one that combines elements from both
approaches, LTACs that are tightly linked to short-stay hospitals facilitating resource sharing
(similar to co-located LTACs), but also large enough to provide complex, multidisciplinary
care to a broad range of patients (similar to free-standing LTACs). This model is not fully sup-
ported by available evidence and should be rigorously tested if implemented. Medicare and
other policy makers have the opportunity to encourage such a model as they revisit LTAC cer-
tifications and reimbursement schemes under the Affordable Care Act. Through bundled pay-
ment mechanisms Medicare could encourage LTACs to partner with short stay hospitals to
avoid readmissions, while at the same time creating standardized admission criteria to prevent
overutilization. The resulting larger LTACs could function as regional referral centers for
chronic critical illness, providing highly skilled care for patients with chronic critical illness
with increased efficiency compared to the current models.
Our study also has implications for the 25% rule, which if fully implemented would limit
LTAC admissions from a single host hospital. On the one hand, given increased mortality at
co-located LTACs, it might seem prudent to limit admissions to these hospitals. On the other
hand, the much larger need to standardize admission criteria across LTACs is not addressed by
the 25% rule, indicating a need to better define criteria for LTAC admission regardless of the
type of the LTAC or the relationship between the LTAC and the short-stay hospital.
Our study has several limitations. First, we studied only Medicare beneficiaries, which are
only a portion of LTAC admissions. However, these patients account for nearly 70% of LTAC
use, and Medicare is the only national data source for LTAC admissions. We also performed
our regression analyses on only a subset of transferred patients, a decision that increased inter-
nal validity but likely further decreased generalizability. Second, we did not have detailed clini-
cal risk-adjustment, meaning that our findings may in part be due to unmeasured
confounding. Nonetheless we used a highly homogenous cohort enhanced through propensity
matching, restricted our analysis only to hospitals that transferred patients to both types of
LTACs, and adjusted for many of the comorbidities known to be associated with outcomes in
chronic critical illness [24]. Third, as in all observational studies we could not fully address for
selection bias. Although our propensity score approach in part addressed selection by matching
on likelihood to be admitted to a co-located LTAC accounting for potential differential mortal-
ity, we could not fully address selection, as might occur if co-located LTACs specifically sought
certain types of patients that may have different outcomes, or the potential impact of other
types of unmeasured confounding, as might occur if patients in co-located LTACs had a greater
severity of illness on transfer. Fourth, we could not address confounding by the short-stay hos-
pital of origin, as might occur if the short-stay hospitals quality is endogenous with LTAC qual-
ity. Given the separation, both fiscal and managerial, between host hospitals and co-located
LTACs, and our other efforts to minimize confounding in the sample, we doubt any influence
was significant. Fifth, the data for this study are now 10 years old, and may not directly related
to modern LTACs utilization patterns. Unfortunately, 2005 is the last year for which reliable
data on LTAC type are available. Sixth, we used total charges and cost-to-charge ratios to esti-
mate costs. Although this approach is the only feasible way to measure costs on a national scale
in the US, it may be inaccurate compared to more granular costing methodology. Our cost
analysis is also limited in that MedPAR only contains inpatient costs. Although inpatient costs
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far exceed outpatient costs for these patients [16], we may have missed some important costs
related to LTAC utilization.
Conclusions
Our study provides new insight into the differences between free-standing and co-located
LTACs. The lower risk of readmission at co-located LTACs creates uncertainty about the value
of policies designed to restrict transfers to these LTACs via the 25% rule. At the same time, the
higher mortality indicates the need for efforts to uncover the mechanism of the mortality dif-
ference so that we can improve the overall quality of care for patients with chronic critical ill-
ness [25].
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